SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,000 | -45.5% | 21,870 | -45.3% | 0.00% | 0.0% |
| Q1 2016 | $22,000 | -38.9% | 40,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $36,000 | +9.1% | 40,000 | -1.2% | 0.00% | +100.0% |
| Q3 2015 | $33,000 | -80.5% | 40,500 | -27.7% | 0.00% | -85.7% |
| Q2 2015 | $169,000 | +24.3% | 56,000 | +0.5% | 0.01% | +16.7% |
| Q1 2015 | $136,000 | -40.9% | 55,700 | -38.1% | 0.01% | -25.0% |
| Q4 2014 | $230,000 | – | 90,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |